The effect of SATB1 on the EGFR level and the progression of non-small cell lung cancers

2017/25/N/NZ5/01651

Keywords

Descriptors

  • NZ5_7: Leczenie chorób człowieka
  • NZ5_5: Diagnostyka chorób człowieka
  • NZ5_3: Patogeneza chorób człowieka

Panel

NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej, Wydział Lekarski

Voivodeship: dolnośląskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

Natalia Małgorzata Glatzel-Plucińska

Number of co-investigators in the project: 3

Call

PRELUDIUM 13 – announced on 2017-03-15

Amount awarded
179 880 PLN
Project start date
2018-01-26
Project end date
2023-01-25
Project duration
60 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (1)

  1. EGFR Levels in NSCLC Are Associated With Expression of SATB1 and EMT‐promoting Factors

    Authors:
    Natalia Glatzel-Plucińska, Aleksandra Piotrowska, Mateusz Olbromski, Adam Rzechonek, Marzenna Podhorska-Okołów, Piotr Dzięgiel
    Status:
    Accepted for publication

« New search

Graphic design and implementation: Jakub Piotrowski